ストックスクリーナーアプリを入手
15.27
5.97%
0.86
プレマーケット:
15.68
0.41
+2.69%
Eton Pharmaceuticals Inc (ETON) 最新ニュース
Eton Pharmaceuticals stock soars to all-time high of $15.11 - MSN
Eton acquires Wilson disease drug Galzin - MSN
14 Best 52-Week High Stocks To Buy According to Analysts - Insider Monkey
Eton Pharmaceuticals, Inc. (ETON): Analysts Recommend This 52-Week High Stocks Now - Insider Monkey
15,006 Shares in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Acquired by Jane Street Group LLC - Defense World
Q1 Earnings Estimate for ETON Issued By B. Riley - Defense World
Q1 Earnings Forecast for ETON Issued By B. Riley - MarketBeat
Eton Pharmaceuticals (NASDAQ:ETON) Upgraded at B. Riley - Defense World
Eton Pharmaceuticals (NASDAQ:ETON) Coverage Initiated at B. Riley - Defense World
Eton Pharmaceuticals (NASDAQ:ETON) Raised to "Strong-Buy" at B. Riley - MarketBeat
When the Price of (ETON) Talks, People Listen - Stock Traders Daily
B. Riley Begins Coverage on Eton Pharmaceuticals (NASDAQ:ETON) - MarketBeat
Craig Hallum Forecasts Strong Price Appreciation for Eton Pharmaceuticals (NASDAQ:ETON) Stock - Defense World
HC Wainwright Issues Positive Forecast for ETON Earnings - Defense World
Q2 EPS Estimate for Eton Pharmaceuticals Lifted by Analyst - MarketBeat
Investing in Eton Pharmaceuticals (NASDAQ:ETON) three years ago would have delivered you a 177% gain - Yahoo Finance
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Position Boosted by Geode Capital Management LLC - Defense World
What is HC Wainwright’s Forecast for ETON FY2027 Earnings? - Defense World
Eton Pharmaceuticals’ Acquisition of Galzin® - Global Legal Chronicle
Eton Pharmaceuticals (NASDAQ:ETON) Price Target Raised to $18.00 at Craig Hallum - MarketBeat
The Analyst Verdict: Eton Pharmaceuticals In The Eyes Of 5 Experts - Benzinga
What is HC Wainwright's Forecast for ETON FY2027 Earnings? - MarketBeat
Eton Pharmaceuticals (NASDAQ:ETON) Price Target Raised to $17.00 - MarketBeat
Eton Pharmaceuticals (NASDAQ:ETON) versus Repare Therapeutics (NASDAQ:RPTX) Financial Survey - Defense World
Eton Pharmaceuticals Acquires FDA-Approved Zinc Treatment for Wilson Disease - Defense World
ETONEton Pharmaceutcials, Inc. Latest Stock News & Market Updates - StockTitan
Eton Pharmaceuticals stock soars to all-time high of $14.05 By Investing.com - Investing.com Australia
Eton acquires Wilson disease drug Galzin (ETON:NASDAQ) - Seeking Alpha
Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin® - GlobeNewswire
Eton Pharmaceuticals Acquires FDA-Approved Wilson Disease Treatment Galzin, Expands Rare Disease Portfolio - StockTitan
Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin - Business Upturn
Eton Pharmaceuticals stock soars to all-time high of $14.05 - Investing.com India
Tesla Inc (TSLA-Q) QuotePress Release - The Globe and Mail
When (ETON) Moves Investors should Listen - Stock Traders Daily
Individual investors who hold 55% of Eton Pharmaceuticals, Inc. (NASDAQ:ETON) gained 11%, institutions profited as well - Simply Wall St
Eton Pharmaceuticals (NASDAQ:ETON) Completes Acquisition of Increlex® from Ipsen S.A. - Defense World
Where are the Opportunities in (ETON) - Stock Traders Daily
Eton Pharmaceuticals, Inc. completed the acquisition of Increlex® from Ipsen Biopharmaceuticals, Inc. - Marketscreener.com
Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection) - The Manila Times
Eton Pharmaceuticals Acquires Rare Growth Disorder Drug Increlex, Expanding Pediatric Treatment Portfolio - StockTitan
Eton Pharmaceuticals Announces Positive Results from Clinical Trial for PKU GOLIKE Protein Substitute - Defense World
Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical Trial - The Manila Times
Eton Pharma's PKU GOLIKE Clinical Trial Shows Breakthrough Results in Metabolic Control - StockTitan
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Short Interest Up 32.6% in November - MarketBeat
Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) top owners are retail investors with 58% stake, while 26% is held by institutions - Yahoo Finance
EcoR1 Capital, LLC Increases Stake in Eton Pharmaceuticals Inc. - GuruFocus.com
The Escalator: AstraZeneca, Eton Pharmaceuticals, AltruBio and more - MM+M Online
Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer - GlobeNewswire
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Sees Significant Increase in Short Interest - Defense World
2.14%
大文字化:
|
ボリューム (24 時間):